Brian Mueller - 02 Dec 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Financial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
02 Dec 2022
Transactions value $
-$331,526
Form type
4
Filing time
06 Dec 2022, 20:29:18 UTC
Previous filing
28 Nov 2022
Next filing
15 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale -$115K -1.1K -3.82% $104.50 27.7K 02 Dec 2022 Direct F1
transaction BMRN Common Stock Options Exercise $145K +2.14K +7.71% $67.81 29.9K 02 Dec 2022 Direct F1
transaction BMRN Common Stock Sale -$224K -2.14K -7.16% $104.50 27.7K 02 Dec 2022 Direct F1
transaction BMRN Common Stock Options Exercise $255K +3.76K +13.56% $67.81 31.5K 02 Dec 2022 Direct F1
transaction BMRN Common Stock Sale -$393K -3.76K -11.94% $104.50 27.7K 02 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -2.14K -100% $0.00* 0 02 Dec 2022 Common Stock 2.14K $67.81 Direct F1, F2
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -3.76K -100% $0.00* 0 02 Dec 2022 Common Stock 3.76K $67.81 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on March 14, 2022.
F2 Reflects the number of options outstanding after the transactions from this specific stock option grant.